Patent · US Active

11-β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors and uses thereof

US8871208B2 · kind B2 · utility

3Cited by

4References

8Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

Peer B. Jacobson · Libertyville, US
Lisa M. Olson · Hopkinton, US
Sreeinvasarao Vepachedu · Vernon Hills, US

Key dates

Filing date	Dec 2, 2010
Grant date	Oct 28, 2014
Priority date	—
Expiry date	Dec 2, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for treating a patient suffering from inflammation, chronic inflammation, pain, rheumatoid arthritis (RA), osteoarthritis and osteoporosis, comprising administering an effective amount of a selective inhibitor of the 11-β-hydroxysteroid dehydrogenase Type 1 enzyme.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.